Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (41-50 of 602) with videos related to

Pageof 61
Sort By:
Ebiomedicine|July 3, 2015
Recent Advances from the Bench Toward the Bedside in Alzheimer's DiseaseShannon L Macauley, David M Holtzman
Nature Neuroscience|May 27, 2015
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Erik S Musiek, David M Holtzman
The Journal of Clinical Investigation|August 5, 2003
Amyloid beta and Alzheimer disease therapeutics: the devil may be in the detailsJohn R Cirrito, David M Holtzman
Nature Neuroscience|June 26, 2015
How amyloid, sleep and memory connectBrendan P Lucey, David M Holtzman
Annals of Neurology|February 21, 2006
Expectations and challenges in the therapeutic use of neurotrophic factorsPaul T Kotzbauer, David M Holtzman
ACS Chemical Neuroscience|February 9, 2016
TREM2 Function in Alzheimer's Disease and NeurodegenerationJason D Ulrich, David M Holtzman
Vaccine|June 24, 2025
Accelerating development of vaccines for prevention and control of Alzheimer's diseaseWayne C Koff, David M Holtzman
Cell|October 1, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment StrategiesJustin M Long, David M Holtzman
Current Opinion in Neurology|October 9, 2012
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvementErik S Musiek, David M Holtzman
Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M Holtzman
Pageof 61

Showing results (41-50 of 602) with videos related to

Sort By:
Pageof 61
Ebiomedicine|July 3, 2015
Recent Advances from the Bench Toward the Bedside in Alzheimer's DiseaseShannon L Macauley, David M Holtzman
Nature Neuroscience|May 27, 2015
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Erik S Musiek, David M Holtzman
The Journal of Clinical Investigation|August 5, 2003
Amyloid beta and Alzheimer disease therapeutics: the devil may be in the detailsJohn R Cirrito, David M Holtzman
Nature Neuroscience|June 26, 2015
How amyloid, sleep and memory connectBrendan P Lucey, David M Holtzman
Annals of Neurology|February 21, 2006
Expectations and challenges in the therapeutic use of neurotrophic factorsPaul T Kotzbauer, David M Holtzman
ACS Chemical Neuroscience|February 9, 2016
TREM2 Function in Alzheimer's Disease and NeurodegenerationJason D Ulrich, David M Holtzman
Vaccine|June 24, 2025
Accelerating development of vaccines for prevention and control of Alzheimer's diseaseWayne C Koff, David M Holtzman
Cell|October 1, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment StrategiesJustin M Long, David M Holtzman
Current Opinion in Neurology|October 9, 2012
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvementErik S Musiek, David M Holtzman
Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M Holtzman
Pageof 61